Findings from two researches prove that a non-invasive and new imaging gadget can see indications of Alzheimer’s disease within seconds. The scientists show that the tiny blood vessels at the back of the eye in the retina are modified in patients suffering from Alzheimer’s. Even people who have an Alzheimer’s family history but have no symptoms, show these telltale indications. And they showed that they can differentiate between people suffering from mild cognitive impairment and those suffering from Alzheimer’s. Findings from these studies are being published at AAO 2018, which is American Academy of Ophthalmology’s 122nd yearly conference of the.
A new type of non-invasive and precise imaging dubbed as OCTA (optical coherence tomography angiography) has helped much of the latest study on the eye’s relation with Alzheimer’s. It allows physicians to see the tinniest veins present at the back of the eye, comprising the red blood cells shifting via the retina.
On a related note, earlier 3D Signatures, a Canada-based firm, invented the TeloView Technology. This technology or rather a system is a platform for software that can examine telomere patterns present in cells in order to analyze a disease. The firm lately declared the outcome of a clinical research, on the verge for publication in the Journal of Alzheimer’s Disease. The report claims that TeloView Technology could reportedly recognize Alzheimer’s disease and forecast if the disease was severe, moderate, or mild, on the basis of examining a cheek swab sample from patients.
Telomeres are formations that guard the peak of our chromosomes. The company has studied the 3D structure of telomeres in diseased as well as healthy cells, keeping in mind to develop diagnostic techniques. They have examined telomere structures in Alzheimer’s disease and in different cancers. The study consisted getting cheek swabs from 44 patients with Alzheimer’s disease and 44 healthy volunteers. T